PlainRecalls
FDA Drug Moderate Class II Terminated

Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.

Reported: January 19, 2022 Initiated: January 5, 2022 #D-0460-2022

Product Description

Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.

Reason for Recall

Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.

Details

Recalling Firm
Akorn, Inc.
Units Affected
31,510 ampules
Distribution
Nationwide in the USA
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous and epidural use, Rx only, 2 mL Ampule, Warning - May be habit forming, Preservative Free, Manufactured by Akorn, Inc. Lake Forest, IL 60045, NDC 17478-0050-02.. Recalled by Akorn, Inc.. Units affected: 31,510 ampules.
Why was this product recalled?
Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 19, 2022. Severity: Moderate. Recall number: D-0460-2022.